NERX BIOSCIENCES, INC.
| 212 W 10TH ST STE A480
INDIANAPOLIS, IN, 46202-5608
|Socially and Economically Disadvantaged:||N|
|Number of Employees:||2|
DESCRIPTION provided by applicant Development of novel lung cancer therapeutics targeting the DNA damage response Abstract Lung tissue is constantly exposed to a wide variety of inhaled chemical a ...STTR Phase I 2015 Department of Health and Human Services National Institutes of Health
DESCRIPTION (provided by applicant): Epithelial ovarian cancer (EOC) is uniformly fatal once resistance to platinum based therapy (Pt) is observed. Innate resistance is observed in approximately 25% o ...STTR Phase I 2012 Department of Health and Human Services
DESCRIPTION (provided by applicant): Platinum based agents (Pt) are the most commonly prescribed chemotherapeutics used in the treatment of solid tumors and are part of the curative treatment regimen ...SBIR Phase I 2012 Department of Health and Human Services